Article
Alternative back-splicing of circular RNAs modulates almonertinib resistance in non-small cell lung cancer
2026-05-21
Abstract excerpt
<title>Abstract</title> <p>Acquired resistance to third-generation EGFR tyrosine kinase inhibitors (TKIs) such as almonertinib presents a major clinical challenge in non-small cell lung cancer (NSCLC). Circular RNAs (circRNAs) are generated via back-splicing, and are versatile players in cancer biology. By using long-read nanopore sequencing, we profiled full-length circRNAs in almonertinib-resistant NSCLC cells...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7dd42b5-dd3d-5d1d-baa6-7c7266112dff
- DOI
- 10.21203/rs.3.rs-9505749/v1
